Note 9 - Segment Information and Disaggregated Revenue (Tables)

9 Months Ended

Mar. 31, 2023

Notes Tables

Schedule of Segment Reporting Information, by Segment [Table Text Block]

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2023	$	10,417	$	2,180	$	12,597	$	978	$	86	$	16
	2022		12,686		2,554		15,240		1,840		82		143
Other Nutraceutical Businesses	2023		493		8		501		30		-		-
	2022		386		8		394		142		1		-
Total Company	2023		10,910		2,188		13,098		1,008		86		16
	2022		13,072		2,562		15,634		1,982		83		143

		Sales, Net						Segment
		U.S.		International				Gross				Capital
		Customers		Customers		Total		Profit		Depreciation		Expenditures
Contract Manufacturing	2023	$	29,272	$	6,568	$	35,840	$	2,745	$	265	$	98
	2022		34,559		7,077		41,636		4,691		244		451
Other Nutraceutical Businesses	2023		1,830		8		1,838		330		2		-
	2022		1,281		62		1,343		465		3		-
Total Company	2023		31,102		6,576		37,678		3,075		267		98
	2022		35,840		7,139		42,979		5,156		247		451

	Total Assets as of
	March 31,		June 30,
	2023		2022
Contract Manufacturing	$	20,830	$	19,061
Other Nutraceutical Businesses		6,050		6,189
Total Company	$	26,880	$	25,250